General Information of the Compound
| Compound ID |
CP0210785
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
Aceclidine
Show/Hide
|
||||||||||||||||||
| Synonyms |
(-)-aceclidine
ACECLIDINE
GTPL288
R-(-)-aceclidine
ZB016005
[(8R)-1-azoniabicyclo[2.2.2]octan-8-yl] acetate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C9H15NO2
|
||||||||||||||||||
| Molecular Weight |
169.224
|
||||||||||||||||||
| Canonical SMILES |
CC(=O)OC1CN2CCC1CC2
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C9H15NO2/c1-7(11)12-9-6-10-4-2-8(9)3-5-10/h8-9H,2-6H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
WRJPSSPFHGNBMG-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
827-61-2
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01310, Muscarinic acetylcholine receptor M1
Protein ID: PT06153, Muscarinic acetylcholine receptor M3
Clinical Information about the Compound
Drug 1 ( ACECLIDINE )
| Drug Name | ACECLIDINE | ||
|---|---|---|---|
| Indication | |||
| Target(s) | |||